2-[[[2-[[(2R)-1-hydroxybutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]amino]methyl]phenol


Chemical Name: 2-[[[2-[[(2R)-1-hydroxybutan-2-yl]amino]-9-propan-2-ylpurin-6-yl]amino]methyl]phenol
CAS Number: 500735-47-7
Product Number: AG00DJY8(AGN-PC-0LR023)
Synonyms:
MDL No: MFCD06411574
Molecular Formula: C19H26N6O2
Molecular Weight: 370.4487

Identification/Properties


Computed Properties
Molecular Weight:
370.457g/mol
XLogP3:
2.8
Hydrogen Bond Donor Count:
4
Hydrogen Bond Acceptor Count:
7
Rotatable Bond Count:
8
Exact Mass:
370.212g/mol
Monoisotopic Mass:
370.212g/mol
Topological Polar Surface Area:
108A^2
Heavy Atom Count:
27
Formal Charge:
0
Complexity:
454
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
1
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
1
Compound Is Canonicalized:
Yes

Safety Information


NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Olomoucine II, a potent inhibitor of cyclin-dependent kinases (CDKs), is a valuable tool in chemical synthesis for controlling cell cycle progression. By targeting specific CDKs, Olomoucine II can modulate cell division and proliferation, making it a useful compound for studying cell cycle regulation. In a chemical synthesis context, Olomoucine II can be employed to manipulate cell cycle checkpoints and arrest cell growth at specific stages, allowing for precise control over cellular processes. This capability opens up opportunities for researchers to explore the mechanisms underlying cell division and replication, and to develop novel strategies for altering cell behavior. In addition to its role in studying cell cycle dynamics, Olomoucine II may also be utilized in drug discovery efforts targeting CDK-related pathways, offering potential therapeutic applications in oncology and other disease areas.